Alejandro A Hidalgo

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Inflammatory Response

Candida Albicans

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Darwuin Arrieta-Mendoza, Bruno Garces, Alejandro A Hidalgo, Víctor Manuel Neira Ramírez, Galia Ramirez, Andrónico Neira-Carrillo, Sergio A Bucarey
Design of a New Vaccine Prototype against Porcine Circovirus Type 2 (PCV2), M. hyopneumoniae and M. hyorhinis Based on Multiple Antigens Microencapsulation with Sulfated Chitosan. Vaccines 12 (5) (2024)
Maité Rodríguez-Díaz, Fabián E Pérez, Paloma M Manosalva, Juan I Cerda, Consuelo F Martínez-Contreras, Aracely Y Mora, Nicolás A Villagra, Sergio A Bucarey, Andrés Barriga, Jorge Escobar, José L Martínez, Alejandro A Hidalgo
Antimicrobial Activity and Phytochemical Characterization of Baccharis concava Pers., a Native Plant of the Central Chilean Coast. Molecules (Basel, Switzerland) 29 (7) (2024)
Maité Rodríguez-Díaz, Fabián E Pérez, Paloma M Manosalva, Juan I Cerda, Consuelo F Martínez-Contreras, Aracely Y Mora, Nicolás A Villagra, Sergio A Bucarey, Andrés Barriga, Jorge Escobar, José L Martínez, Alejandro A Hidalgo
Antimicrobial Activity and Phytochemical Characterization of Baccharis concava Pers., a Native Plant of the Central Chilean Coast. Molecules (Basel, Switzerland) 29 (7) (2024)
Maité Rodríguez-Díaz, Fabián E Pérez, Paloma M Manosalva, Juan I Cerda, Consuelo F Martínez-Contreras, Aracely Y Mora, Nicolás A Villagra, Sergio A Bucarey, Andrés Barriga, Jorge Escobar, José L Martínez, Alejandro A Hidalgo
Antimicrobial Activity and Phytochemical Characterization of Baccharis concava Pers., a Native Plant of the Central Chilean Coast. Molecules (Basel, Switzerland) 29 (7) (2024)
Darwuin Arrieta-Mendoza, Bruno Garces, Alejandro A Hidalgo, Víctor Manuel Neira Ramírez, Galia Ramirez, Andrónico Neira-Carrillo, Sergio A Bucarey
Design of a New Vaccine Prototype against Porcine Circovirus Type 2 (PCV2), M. hyopneumoniae and M. hyorhinis Based on Multiple Antigens Microencapsulation with Sulfated Chitosan. Vaccines 12 (5) (2024)